NCT06029465View on ClinicalTrials.gov

Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2026

Conditions
Rhabdomyosarcoma
Trial Locations (1)

94107

Power Life Sciences, San Francisco

Sponsors
All Listed Sponsors
lead

Power Life Sciences Inc.

INDUSTRY

NCT06029465 - Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials | Biotech Hunter | Biotech Hunter